INS and Hyperglycemia: Prior to the development of short-acting insulin analogs, prandial control with regular human insulin (RHI) often was challenging due to variability in absorption and time to reach peak levels, as well as to frequent hypoglycemia resulting from the use of higher insulin doses to compensate for postprandial hyperglycemia [40].